Alps Advisors Inc Ionis Pharmaceuticals Inc Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $242,442 - $322,859	-6,635 Reduced 7.89%	77,480 $3.43 Million
Q2 2022 Aug 11, 2022	SELL	$31.71 - $43.0 $1.95 Million - $2.64 Million	-61,500 Reduced 42.23%	84,115 $3.11 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $532,132 - $659,645	-17,809 Reduced 10.9%	145,615 $5.39 Million
Q4 2021 Feb 09, 2022	BUY	$25.61 - $35.1 $4.19 Million - $5.74 Million	163,424 New	163,424 $4.97 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.